[{"address1": "Novo Alle 1", "city": "Bagsvaerd", "zip": "2880", "country": "Denmark", "phone": "45 44 44 88 88", "website": "https://www.novonordisk.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.", "fullTimeEmployees": 68794, "companyOfficers": [{"maxAge": 1, "name": "Mr. Karsten Munk Knudsen", "age": 54, "title": "Executive VP, CFO & Member of the Management Board", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 2732220, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maziar Mike Doustdar", "age": 55, "title": "President, CEO & Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ludovic  Helfgott", "age": 51, "title": "Executive VP of Product & Portfolio Strategy and Member of Management Board", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martin Holst Lange", "age": 55, "title": "EVP of R&D, Chief Scientific Officer and Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1937970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tania  Sabroe", "age": 48, "title": "EVP of People, Organisation and Corporate Affairs & Member of Management Board", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David S. Moore", "age": 51, "title": "Executive VP of US Operations & Member of Management Board", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Thilde Hummel Bogebjerg", "age": 43, "title": "Executive VP of Enterprise IT & Quality and Member of Management Board", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Emil Kongshoej Larsen", "age": 50, "title": "EVP of International Operations & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Novod", "age": 46, "title": "Senior VP & Head of Investor Relations", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John F. Kuckelman", "age": 53, "title": "SVP, Group General Counsel, Global Legal, IP & Security", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novonordisk.com/investors/default.asp", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 48.93, "open": 49.3, "dayLow": 49.195, "dayHigh": 49.84, "regularMarketPreviousClose": 48.93, "regularMarketOpen": 49.3, "regularMarketDayLow": 49.195, "regularMarketDayHigh": 49.84, "dividendRate": 1.86, "dividendYield": 3.75, "exDividendDate": 1774828800, "payoutRatio": 0.5042, "fiveYearAvgDividendYield": 1.62, "beta": 0.403, "trailingPE": 13.5437155, "forwardPE": 14.152435, "volume": 9351977, "regularMarketVolume": 9351977, "averageVolume": 21660709, "averageVolume10days": 30478560, "averageDailyVolume10Day": 30478560, "bid": 49.4, "ask": 49.4, "bidSize": 600, "askSize": 300, "marketCap": 220423749632, "fiftyTwoWeekLow": 43.08, "fiftyTwoWeekHigh": 93.8, "allTimeHigh": 148.15, "allTimeLow": 0.08625, "priceToSalesTrailing12Months": 0.7131977, "fiftyDayAverage": 53.3006, "twoHundredDayAverage": 58.2419, "trailingAnnualDividendRate": 11.7, "trailingAnnualDividendYield": 0.2391171, "currency": "USD", "tradeable": false, "enterpriseValue": 324285071360, "profitMargins": 0.33143002, "floatShares": 3188214480, "sharesOutstanding": 3371844674, "sharesShort": 31693294, "sharesShortPriorMonth": 32384787, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0070999996, "heldPercentInsiders": 3.0000001e-05, "heldPercentInstitutions": 0.09076, "shortRatio": 1.48, "shortPercentOfFloat": 0.0094, "impliedSharesOutstanding": 4446716674, "bookValue": 6.9361854, "priceToBook": 7.1465793, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "earningsQuarterlyGrowth": -0.047, "netIncomeToCommon": 102433996800, "trailingEps": 3.66, "forwardEps": 3.5025773, "lastSplitFactor": "2:1", "lastSplitDate": 1695168000, "enterpriseToRevenue": 1.049, "enterpriseToEbitda": 2.115, "52WeekChange": -0.39791083, "SandP52WeekChange": 0.11527538, "lastDividendValue": 0.584, "lastDividendDate": 1755475200, "quoteType": "EQUITY", "currentPrice": 49.57, "targetHighPrice": 69.850464, "targetLowPrice": 42.606476, "targetMeanPrice": 54.37348, "targetMedianPrice": 55.543324, "recommendationMean": 2.15385, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 26961999872, "totalCashPerShare": 6.067, "ebitda": 153294995456, "totalDebt": 130958000128, "quickRatio": 0.539, "currentRatio": 0.8, "totalRevenue": 309064007680, "debtToEquity": 67.488, "revenuePerShare": 69.562, "returnOnAssets": 0.17429, "returnOnEquity": 0.60696, "grossProfits": 254687002624, "freeCashflow": 376875008, "operatingCashflow": 119101997056, "earningsGrowth": -0.047, "revenueGrowth": -0.076, "grossMargins": 0.82405996, "ebitdaMargins": 0.496, "operatingMargins": 0.44528, "financialCurrency": "DKK", "symbol": "NVO", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1771030777, "regularMarketTime": 1771016402, "exchange": "NYQ", "messageBoardId": "finmb_323452", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.30799, "regularMarketPrice": 49.57, "fiftyTwoWeekLowChangePercent": 0.15064989, "fiftyTwoWeekRange": "43.08 - 93.8", "fiftyTwoWeekHighChange": -44.230003, "fiftyTwoWeekHighChangePercent": -0.4715352, "fiftyTwoWeekChangePercent": -39.791084, "dividendDate": 1775606400, "earningsTimestamp": 1770148800, "earningsTimestampStart": 1778074200, "earningsTimestampEnd": 1778074200, "earningsCallTimestampStart": 1770297300, "earningsCallTimestampEnd": 1770297300, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 3.66, "epsForward": 3.5025773, "epsCurrentYear": 21.65983, "priceEpsCurrentYear": 2.2885683, "fiftyDayAverageChange": -3.7305984, "fiftyDayAverageChangePercent": -0.06999168, "twoHundredDayAverageChange": -8.671902, "twoHundredDayAverageChangePercent": -0.14889455, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "cryptoTradeable": false, "shortName": "Novo Nordisk A/S", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 357485400000, "postMarketChangePercent": -0.020170106, "postMarketPrice": 49.56, "postMarketChange": -0.0099983215, "regularMarketChange": 0.639999, "regularMarketDayRange": "49.195 - 49.84", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 21660709, "fiftyTwoWeekLowChange": 6.489998, "marketState": "CLOSED", "longName": "Novo Nordisk A/S", "trailingPegRatio": 4.1258, "__fetch_time": "2026-02-14"}]